Form 8-K - Current report:
SEC Accession No. 0000950170-25-085442
Filing Date
2025-06-12
Accepted
2025-06-12 16:27:42
Documents
10
Period of Report
2025-06-11
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K crnx-20250611.htm   iXBRL 8-K 65238
  Complete submission text file 0000950170-25-085442.txt   171435

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT crnx-20250611.xsd EX-101.SCH 25038
12 EXTRACTED XBRL INSTANCE DOCUMENT crnx-20250611_htm.xml XML 4762
Mailing Address 6055 LUSK BLVD. SAN DIEGO CA 92121
Business Address 6055 LUSK BLVD. SAN DIEGO CA 92121 858-450-6464
Crinetics Pharmaceuticals, Inc. (Filer) CIK: 0001658247 (see all company filings)

EIN.: 263744114 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38583 | Film No.: 251043132
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)